Funder: INDUSTRIAL FARMACEUTICA CANTABRIA S.A.
date_range Duration: from 21 April 1998 to 21 April 1999 (12 months) Finished
euro 61,351.32 EUR

EVALUACION FARMACOLOGICA DEL COMPONENTE PEPTIDO POLISACARIDO DE AM3 EN SISTEMAS LINFOCITARIOS HUMANOS

Call: (INDUSTRIAL FARMACEUTICA CANTABRIA S.A.)

Researchers